Short Interest in Vivani Medical, Inc. (NASDAQ:VANI) Expands By 420.1%

Vivani Medical, Inc. (NASDAQ:VANI) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 938,800 shares, an increase of 420.1% from the February 29th total of 180,500 shares. Approximately 3.4% of the company’s stock are sold short. Based on an average daily trading volume, of 2,970,000 shares, the days-to-cover ratio is currently 0.3 days.

Vivani Medical Stock Performance

NASDAQ:VANI opened at $1.85 on Friday. Vivani Medical has a 12-month low of $0.75 and a 12-month high of $7.80. The stock has a fifty day moving average price of $1.57 and a 200 day moving average price of $1.19.

Institutional Investors Weigh In On Vivani Medical

A number of large investors have recently modified their holdings of VANI. Prelude Capital Management LLC acquired a new position in shares of Vivani Medical during the third quarter worth $25,000. Tower Research Capital LLC TRC acquired a new position in shares of Vivani Medical during the 3rd quarter worth about $34,000. Dimensional Fund Advisors LP purchased a new position in shares of Vivani Medical in the 3rd quarter valued at about $45,000. State Street Corp acquired a new stake in shares of Vivani Medical during the 3rd quarter worth about $63,000. Finally, Charles Schwab Investment Management Inc. purchased a new stake in Vivani Medical during the second quarter worth approximately $36,000. 6.78% of the stock is owned by hedge funds and other institutional investors.

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.